These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6957154)

  • 21. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL; Grundy SM
    JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
    Houlston R; Quiney J; Watts GF; Lewis B
    J R Soc Med; 1988 May; 81(5):274-6. PubMed ID: 3164409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
    Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in composition of high density lipoprotein during gemfibrozil therapy.
    Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
    Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-arrhythmic action of penfenon and clofibrate].
    Ryzhenkov VE; Miroshkin PM
    Patol Fiziol Eksp Ter; 1980; (5):58-61. PubMed ID: 7422376
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathogenesis and management of lipoprotein disorders.
    Schaefer EJ; Levy RI
    N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
    [No Abstract]   [Full Text] [Related]  

  • 29. The Helsinki Heart Study: basic design and randomization procedure.
    Mänttäri M; Elo O; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    Eur Heart J; 1987 Oct; 8 Suppl I():1-29. PubMed ID: 3322826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
    Grundy SM
    Postgrad Med; 1988 Jul; 84(1):217-8, 223-31. PubMed ID: 3164473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of hyperlipidemia and the role of probucol.
    Davignon J
    Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hyperlipidemia with gemfibrozil.
    Hartshorn JC; Deans K
    J Cardiovasc Nurs; 1987 Aug; 1(4):76-80. PubMed ID: 3474354
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of gemfibrozil on serum lipids.
    Samuel P
    Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment.
    De La Iglesia FA; Lewis JE; Buchanan RA; Marcus EL; McMahon G
    Atherosclerosis; 1982 May; 43(1):19-37. PubMed ID: 6807326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
    Ho LT; Li SH; Chou TY; Liu YF; Perng JC; Han HK; Chen JJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Jan; 39(1):1-8. PubMed ID: 3484238
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
    Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs recently released in Belgium: mitoxantrone, gemfibrozil.
    Harvengt C
    Acta Clin Belg; 1986; 41(2):127-30. PubMed ID: 3463107
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK
    Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.